GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (STU:1FX) » Definitions » Gross Margin %

Ananda Pharma (STU:1FX) Gross Margin % : 0.00% (As of Jul. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Ananda Pharma Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Ananda Pharma's Gross Profit for the six months ended in Jul. 2023 was €0.00 Mil. Ananda Pharma's Revenue for the six months ended in Jul. 2023 was €0.00 Mil. Therefore, Ananda Pharma's Gross Margin % for the quarter that ended in Jul. 2023 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Ananda Pharma's Gross Margin % or its related term are showing as below:


STU:1FX's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 47.44
* Ranked among companies with meaningful Gross Margin % only.

Ananda Pharma had a gross margin of N/A% for the quarter that ended in Jul. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Ananda Pharma was 0.00% per year.


Ananda Pharma Gross Margin % Historical Data

The historical data trend for Ananda Pharma's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma Gross Margin % Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
Gross Margin %
- - - - -

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ananda Pharma's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Pharma's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ananda Pharma's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Pharma's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Ananda Pharma's Gross Margin % falls into.


;
;

Ananda Pharma Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Ananda Pharma's Gross Margin for the fiscal year that ended in Jan. 2023 is calculated as

Gross Margin % (A: Jan. 2023 )=Gross Profit (A: Jan. 2023 ) / Revenue (A: Jan. 2023 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

Ananda Pharma's Gross Margin for the quarter that ended in Jul. 2023 is calculated as


Gross Margin % (Q: Jul. 2023 )=Gross Profit (Q: Jul. 2023 ) / Revenue (Q: Jul. 2023 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Ananda Pharma  (STU:1FX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Ananda Pharma had a gross margin of N/A% for the quarter that ended in Jul. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Ananda Pharma Gross Margin % Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Pharma Business Description

Traded in Other Exchanges
N/A
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines